Xcout IntelSign inSubscribe

CryoStasis competitors & alternatives

Life SciencesCanada

The 12 closest competitors and alternatives to CryoStasis among life sciences companies — ranked by similarity to what CryoStasis actually does, not by market-cap band.

12Competitors listed

Subscribe to see CryoStasis’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event

About CryoStasis

CryoStasis is a biotechnology company headquartered in Ottawa, Canada, specializing in the subzero unfrozen bio-preservation of cells, tissues, and organs.

CryoStasis at a glance

CryoStasis is a life sciences company headquartered in Canada. Its most recent funding round closed in July 2023. Xcout tracks 4 named people at CryoStasis, including Aaron Del Duca (CEO).

CryoStasis leadership

  • Aaron Del DucaCEO
  • Jeremy RutkeChief Financial Officer
  • Jan KaminskiExecutive Chairman
  • Thomas AllenCo-Founder, Senior Scientific Advisor

CryoStasis funding rounds

Every round on record:

DateRoundAmountInvestors
—Undisclosed6 named
SeedUndisclosed2 named

Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →

Top 12 CryoStasis competitors

Ranked by semantic similarity — how close each company is to CryoStasis by what it does, using Xcout's live company graph. Click any company for its full profile, or its competitor set.

International Stem Cell CORPISCO · BiotechSan Diego, United States
62% matchPublic

Biotech

International Stem Cell Corporation (ISCO) is a clinical-stage biotechnology firm dedicated to creating therapeutic and biomedical solutions for a global market, spanning North America, Asia, Europe, and beyond. Central to its offerings are products derived from its proprietary human parthenogenetic stem cells, a unique form of pluripotent stem cells. ISCO is actively engaged in developing specialized cell types, such as neural stem cells, which hold promise for treating Parkinson's disease and other disorders affecting the central nervous system. Beyond therapeutics, the company also develops, manufactures, and commercializes anti-aging skincare products and an extensive range of human cell culture products. Its diverse portfolio of human cell culture products serves as vital research tools across numerous scientific disciplines. This includes specialized cells and reagents designed for studying: Dermatology: Skin diseases, toxicology, and wound healing. Cardiovascular & Oncology: Heart and blood vessel conditions, and various cancers. Respiratory: Bronchial and tracheal conditions, toxicity, cystic fibrosis, asthma, and pathogenesis. Reproductive & Urological: Prostate, renal, bladder, corneal, and female reproductive system diseases, as well as general cellular physiology. Musculoskeletal & Metabolic: Skeletal muscle biology, diabetes, insulin pathways, muscle repair, and myotube development. The company also provides adult stem cells for regenerative medicine research and a full complement of reagents and supplements essential for cell growth, staining, and cryopreservation. Distribution of ISCO's skincare range occurs via its website and specialized professional channels, while its human cell culture products reach customers through a dedicated sales force, original equipment manufacturer (OEM) partners, and authorized brand distributors. Established in 2001, International Stem Cell Corporation maintains its headquarters in San Diego, California.

Market cap$2.3M
Employees32
International Stem Cell CORP competitors & alternatives →

Analyze another company

Search any company we track to see its competitive set.

Or describe a company

Paste a short paragraph describing a company or product — we'll find the most similar companies we track, scored 1–100.

See the full profile of CryoStasis and its market

Funding, investors, tech stack, hiring signals, leadership and corporate events — for CryoStasisand every competitor above — in one live dashboard.

Subscribe to Xcout Intel →